Find uplifting stories about heroes, innovations, and solutions
4964 results for "charcot-marie-tooth disease"
A Nashville family transformed their annual Kentucky Derby party into a powerful fundraiser after their daughter was diagnosed with an incurable nerve disease. Last year alone, they raised $75,000 for research into Charcot-Marie-Tooth disease.
A groundbreaking treatment for Huntington's disease just cleared a major hurdle, bringing hope to 240,000 Americans affected by this devastating condition. The experimental therapy could become the first disease-modifying treatment for a disorder that has had none.
A groundbreaking treatment for myotonic dystrophy type 1 reduced toxic proteins by 40% and improved muscle function in patients who've never had disease-modifying options. The New England Journal of Medicine just published results that could lead to the first approved therapy for this progressive, often fatal disease.
Researchers discovered how to disguise healthy mitochondria so they can slip into diseased cells undetected, extending the lives of mice with a fatal genetic disorder. The breakthrough could one day help children born with rare mitochondrial diseases.
A new treatment for a rare kidney disease just passed a major test, bringing hope to 330,000 patients in the U.S. and Europe. Vertex's drug successfully reduced a key disease marker by half in late-stage trials.
Pearl Jam's Eddie Vedder and Canadian director Matt Finlin created a documentary following the race to cure epidermolysis bullosa, a devastating skin disease affecting children worldwide. The Netflix film captures breakthrough research that could unlock treatments for thousands of rare diseases.
For the first time, a gene therapy has shown dramatic results in slowing Huntington's disease, offering hope to 8,000 UK families who've had no treatment options until now. Patients receiving the higher dose experienced 75% less disease progression over three years.
Four leading European research institutes have joined forces to speed up treatments for Alzheimer's, Parkinson's, and other brain diseases affecting millions. The CURE-ND Alliance brings together over 2,500 scientists working to transform how we understand and treat neurodegenerative diseases.
%3Amax_bytes(150000)%3Astrip_icc()%3Afocal(749x0%3A751x2)%2Fjulie-andrews-sound-of-music-Parkinsons-Disease-Conference-052526-0f33fab652114d14ab5f1406111340df.jpg)
At 90, the beloved Mary Poppins star delivered a powerful message at the World Parkinson's Congress, calling for continued efforts to find a cure. Her rare public appearance brought star power and hope to thousands working to stop the disease.
Jeff Carroll learned he carried the gene for deadly Huntington's disease. Instead of giving up, he became a neuroscientist dedicated to finding a cure for the condition killing him.
The FDA has accepted a groundbreaking treatment for Alexander disease for priority review, offering hope to families battling a rare neurological condition that has no approved therapies. If approved by September, zilganersen would become the first medicine ever available for this devastating illness.
A promising treatment for microvillus inclusion disease, a deadly childhood condition, has entered breakthrough therapy talks with the FDA. The oral medication has already shown it can reduce life-sustaining interventions in young patients.
After eliminating trachoma and other neglected tropical diseases, Malawi is leading African nations to make disease prevention a human rights issue at the UN. Twenty-five African countries have now eliminated at least one neglected tropical disease, proving progress is possible.
NYU is solving diseases faster by throwing out the old playbook: instead of keeping scientists in separate buildings, they're mixing engineers, doctors, and AI experts into teams focused on beating specific diseases. Early wins include a startup detecting airborne pathogens and "inverse vaccines" that could cure celiac disease and allergies.
A University of Kentucky scientist is turning Lyme disease bacteria against itself in a promising new treatment approach. The breakthrough comes as tick-borne illnesses have jumped 128% nationwide since 2020.
Heart disease deaths fell by 25,000 between 2022 and 2023, reversing pandemic-era increases. The decline shows that prevention strategies are working, and experts say simple daily habits could save even more lives.
A drug already used for diabetic kidney disease just proved it can help the other half of kidney patients too, slowing disease progression by 23%. For 674 million people living with chronic kidney disease, this could mean more time before their kidneys fail.
Patients with a rare liver disease finally have relief from debilitating itching that robbed them of sleep and quality of life. The FDA just approved the first treatment specifically designed to ease this painful symptom that affected thousands.
A groundbreaking gene therapy called AMT-130 has slowed Huntington's disease progression by 75% in clinical trials, offering hope to families who've waited 154 years for effective treatment. The one-time treatment could preserve patients' ability to walk, speak, and connect with loved ones for years longer.
Pfizer and Valneva's experimental Lyme disease vaccine proved highly effective in Phase III trials, bringing hope to millions who love the outdoors. If approved, it would be the first Lyme vaccine available in two decades.
Showing 20 of 4964